KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

JCO Precis Oncol · 2025-Jan · PMID 39854658

Panel C质量警告待 EXE 对齐验证

distant recurrence-free interval

Figure 3 A, Bar plot demonstrating the proportion of HER2-low tumours and HER2-zero tumours by age groups in BIG 1–98. B, Bar plot demonstrating the proportion of HER2-low tumours and HER2-zero tumours by age group in premenopausal SOFT cohort. C, Kaplan Meier estimate of distant recurrence-free interval by HER2-low status in postmenopausal BIG 1–98 cohort. D, Kaplan Meier estimate of distant recurrence-free interval by HER2-low status in SOFT premenopausal cohort. The hazard ratio characterises HER2-low relative to HER2-zero. Abbreviations: HR, hazard ratio; 95%CI, 95% confidence interval.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.58
质量通过否
预期曲线2
实际曲线1
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-23T18:24:40+00:00